ArticleBiomedical reports2025

Semaglutide vs. dulaglutide for glycemic and weight control in patients with type 2 diabetes mellitus: A systematic review and meta‑analysis.

Lili Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.